This response of IL-37 to inflammatory processes, such as atherosclerosis, leads to the idea that it functions as a negative feedback mechanism, to diminish the atherogenic effects of excessive inflammation [7,15,16]. The gene discussed is IL37; the disease is atherosclerosis.